A citation-based method for searching scientific literature

Janis M Taube, Robert A Anders, Geoffrey D Young, Haiying Xu, Rajni Sharma, Tracee L McMiller, Shuming Chen, Alison P Klein, Drew M Pardoll, Suzanne L Topalian, Lieping Chen. Sci Transl Med 2012
Times Cited: 1566



Weiping Zou, Jedd D Wolchok, Lieping Chen. Sci Transl Med 2016
Times Cited: 1327




List of shared articles



Times cited

Molecular structure, expression, and the emerging role of Siglec-15 in skeletal biology and cancer.
Sarah Rashid, Dezhi Song, Jinbo Yuan, Benjamin H Mullin, Jiake Xu. J Cell Physiol 2022
1

Programmed death ligand 1 signals in cancer cells.
Anand V R Kornepati, Ratna K Vadlamudi, Tyler J Curiel. Nat Rev Cancer 2022
13

Knocking down Siglec-15 in osteosarcoma cells inhibits proliferation while promoting apoptosis and pyroptosis by targeting the Siglec-15/STAT3/Bcl-2 pathway.
Keliang Song, Jinfeng Ma, Yang Gao, Yan Qu, Chongmin Ren, Peng Yan, Bingxin Zheng, Bin Yue. Adv Med Sci 2022
0


Resistance Mechanisms to Anti-PD Cancer Immunotherapy.
Matthew D Vesely, Tianxiang Zhang, Lieping Chen. Annu Rev Immunol 2022
5

CMTM6 and CMTM4 as two novel regulators of PD-L1 modulate the tumor microenvironment.
Tong Zhang, Haixiang Yu, Xiangpeng Dai, Xiaoling Zhang. Front Immunol 2022
0

Research progress of tumor targeted drug delivery based on PD-1/PD-L1.
Dongzhu Liu, Shan Gao, Yujia Zhai, Xiaoye Yang, Guangxi Zhai. Int J Pharm 2022
4

Interferon-γ induces tumor resistance to anti-PD-1 immunotherapy by promoting YAP phase separation.
Man Yu, Zhengxin Peng, Min Qin, Yang Liu, Jingning Wang, Cai Zhang, Jiaming Lin, Tianqi Dong, Lulu Wang, Shasha Li,[...]. Mol Cell 2021
34